Advanced search

  • Ginekologia Polska
  • Vol 95, No 4 (2024) Inflammation in recurrent miscarriage — a comprehensive perspective from uterine microenvironment and immune cell imbalance to therapeutic strategies
Vol 95, No 4 (2024)
Review paper
Published online: 2024-01-25

open access

View PDF Download PDF file
Page views 508
Article views/downloads 697
Get Citation

Connect on Social Media

Connect on Social Media

Inflammation in recurrent miscarriage — a comprehensive perspective from uterine microenvironment and immune cell imbalance to therapeutic strategies

Mengsi Lin1, Hui Xu1, Jiaying Qiu1
DOI: 10.5603/gpl.97320
Pubmed: 38334340
Ginekol Pol 2024;95(4):266-275.

Abstract

Recurrent miscarriage, poses a significant challenge for many couples globally, the causes of which are not fully understood. Recent studies have shown the intricate link between uterine inflammation and recurrent miscarriages. While inflammation is essential during early pregnancy stages, especially in embryo implantation, an imbalance can lead to miscarriage. Key inflammatory mediators and an imbalance in immune cells can significantly alter and contribute to recurrent miscarriages. Lifestyle factors like smoking and obesity exacerbate inflammatory responses, increasing miscarriage risks. Understanding the interaction between the uterine environment, immune cell imbalances, and recurrent miscarriages is essential for devising effective treatments. This paper presents the latest data on inflammation's role in recurrent miscarriage, emphasizing the significance of diagnosing chronic endometritis and immune imbalances, offering practical recommendations for treatment and diagnosis.

Keywords: endometriumimmune cellsrecurrent miscarriageinflammatory cytokines

Article available in PDF format

View PDF Download PDF file

References

  1. Rai R, Regan L. Recurrent miscarriage. The Lancet. 2006; 368(9535): 601–611.
    CrossRef
  2. Eskandarian M, Moazzeni SM. Uterine Dendritic Cells Modulation by Mesenchymal Stem Cells Provides A Protective Microenvironment at The Feto-Maternal Interface: Improved Pregnancy Outcome in Abortion-Prone Mice. Cell J. 2019; 21(3): 274–280.
    CrossRefPubMed
  3. Wang W, Feng D, Ling B. Biologia Futura: endometrial microbiome affects endometrial receptivity from the perspective of the endometrial immune microenvironment. Biol Futur. 2022; 73(3): 291–300.
    CrossRefPubMed
  4. Krieg S, Westphal L. Immune Function and Recurrent Pregnancy Loss. Semin Reprod Med. 2015; 33(4): 305–312.
    CrossRefPubMed
  5. Vomstein K, Feil K, Strobel L, et al. Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art. J Clin Med. 2021; 10(4).
    CrossRefPubMed
  6. Sharma R, Biedenharn KR, Fedor JM, et al. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol. 2013; 11: 66.
    CrossRefPubMed
  7. Laird SM, Tuckerman EM, Cork BA, et al. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update. 2003; 9(2): 163–174.
    CrossRefPubMed
  8. Kwak-Kim J, Bao S, Lee SKi, et al. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014; 72(2): 129–140.
    CrossRefPubMed
  9. Elder S, Bortoletto P, Romanski PA, et al. Chronic endometritis in women with suspected retained products of conception and their reproductive outcomes. Am J Reprod Immunol. 2021; 86(2): e13410.
    CrossRefPubMed
  10. Kasius JC, Fatemi HM, Bourgain C, et al. The impact of chronic endometritis on reproductive outcome. Fertil Steril. 2011; 96(6): 1451–1456.
    CrossRefPubMed
  11. McQueen DB, Bernardi LA, Stephenson MD. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril. 2014; 101(4): 1026–1030.
    CrossRefPubMed
  12. McQueen DB, Perfetto CO, Hazard FK, et al. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril. 2015; 104(4): 927–931.
    CrossRefPubMed
  13. Kimura F, Takebayashi A, Ishida M, et al. Review: Chronic endometritis and its effect on reproduction. J Obstet Gynaecol Res. 2019; 45(5): 951–960.
    CrossRefPubMed
  14. Bouet PE, El Hachem H, Monceau E, et al. Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril. 2016; 105(1): 106–110.
    CrossRefPubMed
  15. Biberoglu E, Kirbas A, Daglar K, et al. Role of inflammation in intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Res. 2016; 42(3): 252–257.
    CrossRefPubMed
  16. Moreno I, Cicinelli E, Garcia-Grau I, et al. The diagnosis of chronic endometritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology. Am J Obstet Gynecol. 2018; 218(6): 602.e1–602.e16.
    CrossRefPubMed
  17. Sirota I, Zarek SM, Segars JH. Potential influence of the microbiome on infertility and assisted reproductive technology. Semin Reprod Med. 2014; 32(1): 35–42.
    CrossRefPubMed
  18. Hashimoto T, Kyono K. Does dysbiotic endometrium affect blastocyst implantation in IVF patients? J Assist Reprod Genet. 2019; 36(12): 2471–2479.
    CrossRefPubMed
  19. Cicinelli E, Matteo M, Tinelli R, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod. 2015; 30(2): 323–330.
    CrossRefPubMed
  20. Bardos J, Fiorentino D, Longman RE, et al. Immunological Role of the Maternal Uterine Microbiome in Pregnancy: Pregnancies Pathologies and Alterated Microbiota. Front Immunol. 2019; 10: 2823.
    CrossRefPubMed
  21. Liu J, Wu S, Wang ZK, et al. Effect of different antibiotic therapies on the reproductive outcomes of fresh embryo transfer for chronic endometritis: A retrospective cohort study. Am J Reprod Immunol. 2023; 89(3): e13669.
    CrossRefPubMed
  22. Liu J, Liu ZAi, Liu Y, et al. Impact of antibiotic treatment for chronic endometritis on pregnancy outcomes in women with reproductive failures (RIF and RPL): A systematic review and meta-analysis. Front Med (Lausanne). 2022; 9: 980511.
    CrossRefPubMed
  23. Zhang X, Wei H. Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications. Front Immunol. 2021; 12: 728291.
    CrossRefPubMed
  24. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. 2014; 124(5): 1872–1879.
    CrossRefPubMed
  25. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001; 60(3): 349–356.
    CrossRefPubMed
  26. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995; 63(3): 289–302.
    CrossRefPubMed
  27. Johnson RW. Inhibition of growth by pro-inflammatory cytokines: an integrated view. J Anim Sci. 1997; 75(5): 1244–1255.
    CrossRefPubMed
  28. Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update. 2006; 12(3): 209–232.
    CrossRefPubMed
  29. Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, et al. Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clin Rev Allergy Immunol. 2017; 53(1): 40–53.
    CrossRefPubMed
  30. Abramiuk M, Grywalska E, Małkowska P, et al. The Role of the Immune System in the Development of Endometriosis. Cells. 2022; 11(13): 2028.
    CrossRefPubMed
  31. Lédée N, Petitbarat M, Prat-Ellenberg L, et al. The uterine immune profile: A method for individualizing the management of women who have failed to implant an embryo after IVF/ICSI. J Reprod Immunol. 2020; 142: 103207.
    CrossRefPubMed
  32. Liu Y, Chen H, Feng L, et al. Interactions between gut microbiota and metabolites modulate cytokine network imbalances in women with unexplained miscarriage. NPJ Biofilms Microbiomes. 2021; 7(1): 24.
    CrossRefPubMed
  33. Zhong Z, Wang Y, Wang G, et al. Case Report: TNF-Alpha Inhibitors to Rescue Pregnancy in Women With Potential Pregnancy Loss: A Report of Ten Cases. Front Immunol. 2022; 13: 900537.
    CrossRefPubMed
  34. Banerjee P, Ghosh S, Dutta M, et al. Identification of key contributory factors responsible for vascular dysfunction in idiopathic recurrent spontaneous miscarriage. PLoS One. 2013; 8(11): e80940.
    CrossRefPubMed
  35. Jasper MJ, Tremellen KP, Robertson SA. Reduced expression of IL-6 and IL-1alpha mRNAs in secretory phase endometrium of women with recurrent miscarriage. J Reprod Immunol. 2007; 73(1): 74–84.
    CrossRefPubMed
  36. Mariee N, Li TC, Laird SM. Expression of leukaemia inhibitory factor and interleukin 15 in endometrium of women with recurrent implantation failure after IVF; correlation with the number of endometrial natural killer cells. Hum Reprod. 2012; 27(7): 1946–1954.
    CrossRefPubMed
  37. Unfried G, Tempfer C, Schneeberger C, et al. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril. 2001; 75(4): 683–687.
    CrossRefPubMed
  38. Pantos K, Grigoriadis S, Maziotis E, et al. The Role of Interleukins in Recurrent Implantation Failure: A Comprehensive Review of the Literature. Int J Mol Sci. 2022; 23(4).
    CrossRefPubMed
  39. Tao Yu, Li YH, Piao HL, et al. CD56(bright)CD25+ NK cells are preferentially recruited to the maternal/fetal interface in early human pregnancy. Cell Mol Immunol. 2015; 12(1): 77–86.
    CrossRefPubMed
  40. Xu X, Zhou Y, Wei H. Roles of HLA-G in the Maternal-Fetal Immune Microenvironment. Front Immunol. 2020; 11: 592010.
    CrossRefPubMed
  41. Wei H, Liu Su, Lian R, et al. Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage. Reprod Sci. 2020; 27(8): 1656–1664.
    CrossRefPubMed
  42. Yang X, Tian Y, Zheng L, et al. The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses. Int J Mol Sci. 2022; 24(1).
    CrossRefPubMed
  43. Palomares O, Martín-Fontecha M, Lauener R, et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. Genes Immun. 2014; 15(8): 511–520.
    CrossRefPubMed
  44. Sanjabi S, Zenewicz LA, Kamanaka M, et al. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009; 9(4): 447–453.
    CrossRefPubMed
  45. Taylor A, Verhagen J, Blaser K, et al. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology. 2006; 117(4): 433–442.
    CrossRefPubMed
  46. Nagaeva O, Jonsson L, Mincheva-Nilsson L. Dominant IL-10 and TGF-beta mRNA expression in gammadeltaT cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol. 2002; 48(1): 9–17.
    CrossRefPubMed
  47. Terzieva A, Dimitrova V, Djerov L, et al. Early Pregnancy Human Decidua is Enriched with Activated, Fully Differentiated and Pro-Inflammatory Gamma/Delta T Cells with Diverse TCR Repertoires. Int J Mol Sci. 2019; 20(3).
    CrossRefPubMed
  48. Wang WJ, Hao CF, Qu QL, et al. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod. 2010; 25(10): 2591–2596.
    CrossRefPubMed
  49. Alkhuriji A, Omar SAl, Babay Z, et al. Association of IL-1β, IL-6, TNF-α, and TGFβ1 Gene Polymorphisms with Recurrent Spontaneous Abortion in Polycystic Ovary Syndrome. Dis Markers. 2020; 2020: 1–8.
    CrossRefPubMed
  50. Ma J, Zhang X, He G, et al. Association between TNF, IL1B, IL6, IL10 and IFNG polymorphisms and recurrent miscarriage: a case control study. Reprod Biol Endocrinol. 2017; 15(1): 83.
    CrossRefPubMed
  51. Vesce F, Battisti C, Crudo M. The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia. Front Immunol. 2022; 13: 861245.
    CrossRefPubMed
  52. Bagkou Dimakou D, Lissauer D, Tamblyn J, et al. Understanding human immunity in idiopathic recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2022; 270: 17–29.
    CrossRefPubMed
  53. Niringiyumukiza JD, Cai H, Xiang W. Prostaglandin E2 involvement in mammalian female fertility: ovulation, fertilization, embryo development and early implantation. Reprod Biol Endocrinol. 2018; 16(1): 43.
    CrossRefPubMed
  54. Mayoral Andrade G, Vásquez Martínez G, Pérez-Campos Mayoral L, et al. Molecules and Prostaglandins Related to Embryo Tolerance. Front Immunol. 2020; 11: 555414.
    CrossRefPubMed
  55. Nannan Mi, Xiaoping L, Ying J. Periodontal disease in pregnancy and adverse pregnancy outcomes: Progress in related mechanisms and management strategies. Front Med (Lausanne). 2022; 9: 963956.
    CrossRefPubMed
  56. Zhang S, Lin H, Kong S, et al. Physiological and molecular determinants of embryo implantation. Mol Aspects Med. 2013; 34(5): 939–980.
    CrossRefPubMed
  57. Reyes L, Phillips P, Wolfe B, et al. and adverse pregnancy outcome. J Oral Microbiol. 2018; 10(1): 1374153.
    CrossRefPubMed
  58. Wang W, Sung N, Gilman-Sachs A, et al. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells. Front Immunol. 2020; 11: 2025.
    CrossRefPubMed
  59. Lee JiY, Lee M, Lee SKi. Role of endometrial immune cells in implantation. Clin Exp Reprod Med. 2011; 38(3): 119–125.
    CrossRefPubMed
  60. Huang N, Chi H, Qiao J. Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases. Front Immunol. 2020; 11: 1023.
    CrossRefPubMed
  61. Tsuda S, Nakashima A, Shima T, et al. New Paradigm in the Role of Regulatory T Cells During Pregnancy. Front Immunol. 2019; 10: 573.
    CrossRefPubMed
  62. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update. 2009; 15(5): 517–535.
    CrossRefPubMed
  63. Keller CC, Eikmans M, van der Hoorn MLP, et al. Recurrent miscarriages and the association with regulatory T cells; A systematic review. J Reprod Immunol. 2020; 139: 103105.
    CrossRefPubMed
  64. Crosby DA, Glover LE, Brennan EP, et al. Dysregulation of the interleukin-17A pathway in endometrial tissue from women with unexplained infertility affects pregnancy outcome following assisted reproductive treatment. Hum Reprod. 2020; 35(8): 1875–1888.
    CrossRefPubMed
  65. Pallmer K, Oxenius A. Recognition and Regulation of T Cells by NK Cells. Front Immunol. 2016; 7: 251.
    CrossRefPubMed
  66. Jena MK, Nayak N, Chen K, et al. Role of Macrophages in Pregnancy and Related Complications. Arch Immunol Ther Exp (Warsz). 2019; 67(5): 295–309.
    CrossRefPubMed
  67. Savva C, Copson E, Johnson PWM, et al. Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies. Cancers (Basel). 2023; 15(9).
    CrossRefPubMed
  68. Li D, Zheng L, Zhao D, et al. The Role of Immune Cells in Recurrent Spontaneous Abortion. Reprod Sci. 2021; 28(12): 3303–3315.
    CrossRefPubMed
  69. Ding J, Yin T, Yan N, et al. FasL on decidual macrophages mediates trophoblast apoptosis: A potential cause of recurrent miscarriage. Int J Mol Med. 2019; 43(6): 2376–2386.
    CrossRefPubMed
  70. Xie M, Li Y, Meng YZ, et al. Uterine Natural Killer Cells: A Rising Star in Human Pregnancy Regulation. Front Immunol. 2022; 13: 918550.
    CrossRefPubMed
  71. Sharma S. Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol. 2014; 58(2-4): 219–229.
    CrossRefPubMed
  72. Sfakianoudis K, Rapani A, Grigoriadis S, et al. The Role of Uterine Natural Killer Cells on Recurrent Miscarriage and Recurrent Implantation Failure: From Pathophysiology to Treatment. Biomedicines. 2021; 9(10): 1425.
    CrossRefPubMed
  73. Woon EeV, Nikolaou D, MacLaran K, et al. Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 in reproductive failure. Front Immunol. 2022; 13: 1108163.
    CrossRefPubMed
  74. Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2014; 20(3): 429–438.
    CrossRefPubMed
  75. Quenby S, Kalumbi C, Bates M, et al. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril. 2005; 84(4): 980–984.
    CrossRefPubMed
  76. Tang AW, Alfirevic Z, Turner MA, et al. Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials. 2009; 10: 102.
    CrossRefPubMed
  77. El Hachem H, Crepaux V, May-Panloup P, et al. Recurrent pregnancy loss: current perspectives. Int J Womens Health. 2017; 9: 331–345.
    CrossRefPubMed
  78. Faas MM, de Vos P. Uterine NK cells and macrophages in pregnancy. Placenta. 2017; 56: 44–52.
    CrossRefPubMed
  79. Devvanshi H, Kachhwaha R, Manhswita A, et al. Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes. Front Pharmacol. 2022; 13: 895254.
    CrossRefPubMed
  80. Ishida Y, Zhao D, Ohkuchi A, et al. Maternal peripheral blood natural killer cells incorporate placenta-associated microRNAs during pregnancy. Int J Mol Med. 2015; 35(6): 1511–1524.
    CrossRefPubMed
  81. Kalkunte SS, Mselle TF, Norris WE, et al. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol. 2009; 182(7): 4085–4092.
    CrossRefPubMed
  82. Ghafourian M, Karami N, Khodadadi A, et al. Increase of CD69, CD161 and CD94 on NK cells in women with recurrent spontaneous abortion and in vitro fertilization failure. Iran J Immunol. 2014; 11(2): 84–96.
    PubMed
  83. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002; 2(9): 656–663.
    CrossRefPubMed
  84. Lash GE, Schiessl B, Kirkley M, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006; 80(3): 572–580.
    CrossRefPubMed
  85. Saghian R, Bogle G, James JL, et al. Establishment of maternal blood supply to the placenta: insights into plugging, unplugging and trophoblast behaviour from an agent-based model. Interface Focus. 2019; 9(5): 20190019.
    CrossRefPubMed
  86. Robson A, Harris LK, Innes BA, et al. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J. 2012; 26(12): 4876–4885.
    CrossRefPubMed
  87. Pollheimer J, Vondra S, Baltayeva J, et al. Regulation of Placental Extravillous Trophoblasts by the Maternal Uterine Environment. Front Immunol. 2018; 9: 2597.
    CrossRefPubMed
  88. Mahajan D, Sharma N, Kancharla S, et al. Role of Natural Killer Cells during Pregnancy and Related Complications. Biomolecules. 2022; 12(1): 68.
    CrossRefPubMed
  89. Walton EL. The inflammasome: Friend or foe in Chlamydia infection? Biomed J. 2016; 39(5): 299–303.
    CrossRefPubMed
  90. Grewal K, Lee YS, Smith A, et al. Chromosomally normal miscarriage is associated with vaginal dysbiosis and local inflammation. BMC Med. 2022; 20(1): 38.
    CrossRefPubMed
  91. Buzzaccarini G, Vitagliano A, Andrisani A, et al. Chronic endometritis and altered embryo implantation: a unified pathophysiological theory from a literature systematic review. J Assist Reprod Genet. 2020; 37(12): 2897–2911.
    CrossRefPubMed
  92. Cicinelli E, Matteo M, Tinelli R, et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014; 21(5): 640–647.
    CrossRefPubMed
  93. Khedkar R, Pajai S. Bacterial Vaginosis: A Comprehensive Narrative on the Etiology, Clinical Features, and Management Approach. Cureus. 2022; 14(11): e31314.
    CrossRefPubMed
  94. Turesheva A, Aimagambetova G, Ukybassova T, et al. Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box. J Clin Med. 2023; 12(12).
    CrossRefPubMed
  95. Malhotra M, Sood S, Mukherjee A, et al. Genital Chlamydia trachomatis: an update. Indian J Med Res. 2013; 138(3): 303–316.
    PubMed
  96. Pacchiarotti A, Sbracia M, Mohamed MA, et al. Autoimmune response to Chlamydia trachomatis infection and in vitro fertilization outcome. Fertil Steril. 2009; 91(3): 946–948.
    CrossRefPubMed
  97. Baud D, Goy G, Jaton K, et al. Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis. 2011; 17(9): 1630–1635.
    CrossRefPubMed
  98. Racicot K, Mor G. Risks associated with viral infections during pregnancy. Journal of Clinical Investigation. 2017; 127(5): 1591–1599.
    CrossRef
  99. Moffett A, Regan L, Braude P. Natural killer cells, miscarriage, and infertility. BMJ. 2004; 329(7477): 1283–1285.
    CrossRefPubMed
  100. Giakoumelou S, Wheelhouse N, Cuschieri K, et al. The role of infection in miscarriage. Hum Reprod Update. 2016; 22(1): 116–133.
    CrossRefPubMed
  101. Phupong V. Dengue fever in pregnancy: a case report. BMC Pregnancy Childbirth. 2001; 1(1): 7.
    CrossRefPubMed
  102. Cornish EF, Filipovic I, Åsenius F, et al. Innate Immune Responses to Acute Viral Infection During Pregnancy. Front Immunol. 2020; 11: 572567.
    CrossRefPubMed
  103. Chudnovets A, Liu J, Narasimhan H, et al. Role of Inflammation in Virus Pathogenesis during Pregnancy. J Virol. 2020; 95(2).
    CrossRefPubMed
  104. Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011; 342: d2616.
    CrossRefPubMed
  105. Heydarifard Z, Zadheidar S, Yavarian J, et al. Potential role of viral infections in miscarriage and insights into the underlying molecular mechanisms. Congenit Anom (Kyoto). 2022; 62(2): 54–67.
    CrossRefPubMed
  106. Di Prima FAF, Valenti O, Hyseni E, et al. Antiphospholipid Syndrome during pregnancy: the state of the art. J Prenat Med. 2011; 5: 41–53.
    PubMed
  107. Gao R, Zeng X, Qin L. Systemic autoimmune diseases and recurrent pregnancy loss: research progress in diagnosis and treatment. Chin Med J (Engl). 2021; 134(17): 2140–2142.
    CrossRefPubMed
  108. Marder W. Update on pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol. 2019; 31(6): 650–658.
    CrossRefPubMed
  109. Gluhovschi C, Gluhovschi G, Petrica L, et al. Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus--An Immunological Dilemma. J Immunol Res. 2015; 2015: 241547.
    CrossRefPubMed
  110. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005; 32(9): 1709–1712.
    PubMed
  111. Ruiz D, Oates JC, Kamen DL. Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus. Am J Med Sci. 2018; 355(3): 293–298.
    CrossRefPubMed
  112. Santos Td, Ieque AL, de Carvalho HC, et al. Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis. J Reprod Immunol. 2017; 123: 78–87.
    CrossRefPubMed
  113. Vinatier D, Dufour P, Cosson M, et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol. 2001; 96(1): 37–50.
    CrossRefPubMed
  114. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996; 174(5): 1584–1589.
    CrossRefPubMed
  115. Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005; 2005(2): CD002859.
    CrossRefPubMed
  116. Abdullahi ZG, Abdul MA, Aminu SM, et al. Antiphospholipid antibodies among pregnant women with recurrent fetal wastage in a tertiary hospital in Northern Nigeria. Ann Afr Med. 2016; 15(3): 133–137.
    CrossRefPubMed
  117. Alijotas-Reig J, Garrido-Gimenez C. Current concepts and new trends in the diagnosis and management of recurrent miscarriage. Obstet Gynecol Surv. 2013; 68(6): 445–466.
    CrossRefPubMed
  118. Ghimire PR, Akombi-Inyang BJ, Tannous C, et al. Association between obesity and miscarriage among women of reproductive age in Nepal. PLoS One. 2020; 15(8): e0236435.
    CrossRefPubMed
  119. Moore TA, Ahmad IM, Schmid KK, et al. Oxidative Stress Levels Throughout Pregnancy, at Birth, and in the Neonate. Biol Res Nurs. 2019; 21(5): 485–494.
    CrossRefPubMed
  120. Ardalić D, Stefanović A, Kotur-Stevuljević J, et al. The influence of maternal smoking habits before pregnancy and antioxidative supplementation during pregnancy on oxidative stress status in a non-complicated pregnancy. Adv Clin Exp Med. 2014; 23(4): 575–583.
    CrossRefPubMed
  121. Firns S, Cruzat VF, Keane KN, et al. The effect of cigarette smoking, alcohol consumption and fruit and vegetable consumption on IVF outcomes: a review and presentation of original data. Reprod Biol Endocrinol. 2015; 13: 134.
    CrossRefPubMed
  122. Grippo A, Zhang J, Chu Li, et al. Air pollution exposure during pregnancy and spontaneous abortion and stillbirth. Rev Environ Health. 2018; 33(3): 247–264.
    CrossRefPubMed
  123. Martins Costa Gomes G, Karmaus W, Murphy VE, et al. Environmental Air Pollutants Inhaled during Pregnancy Are Associated with Altered Cord Blood Immune Cell Profiles. Int J Environ Res Public Health. 2021; 18(14).
    CrossRefPubMed
  124. Magnus MC, Hockey RL, Håberg SE, et al. Pre-pregnancy lifestyle characteristics and risk of miscarriage: the Australian Longitudinal Study on Women's Health. BMC Pregnancy Childbirth. 2022; 22(1): 169.
    CrossRefPubMed
  125. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180: 114147.
    CrossRefPubMed
  126. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003; 327(7411): 368.
    CrossRefPubMed
  127. Shi Y, Tan D, Hao B, et al. Efficacy of intravenous immunoglobulin in the treatment of recurrent spontaneous abortion: A systematic review and meta-analysis. Am J Reprod Immunol. 2022; 88(5): e13615.
    CrossRefPubMed
  128. Habets DHJ, Pelzner K, Wieten L, et al. Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2022; 18(1): 23.
    CrossRefPubMed
  129. Hamulyák EN, Scheres LJj, Marijnen MC, et al. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database Syst Rev. 2020; 5(5): CD012852.
    CrossRefPubMed
  130. Baiazid L, Hraib M. Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome. Ann Med Surg (Lond). 2022; 83: 104807.
    CrossRefPubMed
  131. Talukdar A, Rai R, Aparna Sharma K, et al. Peripheral Gamma Delta T cells secrete inflammatory cytokines in women with idiopathic recurrent pregnancy loss. Cytokine. 2018; 102: 117–122.
    CrossRefPubMed
  132. Agarwal A, Rana M, Qiu E, et al. Role of oxidative stress, infection and inflammation in male infertility. Andrologia. 2018; 50(11): e13126.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Ginekologia Polska

About Via Medica Advertising
Bookstore (Ikamed) TVMed
News
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice